resources

Marksans Pharma Ltd.

NSE: MARKSANS

BSE: 524404

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

263.45+2.3 (+0.86%)

8 Jul, 12:00 AM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Marksans Pharma Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Annual Reports	FY 2013	FY 2014	FY 2015	FY 2016	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	—
Quarterly Results	—	—	—	—	—	Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar
Conference Calls	—	—	—	—	—	—	—	—	19Feb	6Jun 19Aug 21Nov	21Feb 7Jun 22Aug 16Nov	20Feb 5Jun 22Aug 25Nov	25Feb 25Feb 26May 19Aug 21Nov	12Feb 3Jun
Presentations	—	—	—	—	—	—	—	—	8Feb 31May 11Aug 10Nov	11Feb 30May 13Aug 14Nov	13Feb 30May 11Aug 9Nov	13Feb 30May 13Aug 12Nov	11Feb 19May 12Aug 13Nov	5Feb 26May

Corporate Announcements and Regulatory Filings

Marksans Pharma Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

Press Release / Media Release8 Jul 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Marksans Pharma signed a definitive agreement to acquire 100 percent share capital of a German based Company namely ABCnow GmbH
Date of payment of Dividend3 Jul 2026
Announcement under Regulation 30 (LODR)-Date of payment of Dividend
Pl find attached announcement related to record date for payment of dividend, AGM date and dividend payment date.
Dividend Updates3 Jul 2026
Announcement under Regulation 30 (LODR)-Dividend Updates
The Board of Directors of Marksans Pharma Limited fixed 20 August 2026 as the Record Date for payment of dividend.
AGM3 Jul 2026
The Annual General Meeting Of The Marksans Pharma Limited Is Scheduled To Be Held On 27 August 2026.
The Board of Directors of Marksans Pharma Limited in its meeting held on 3 July 2026 fixed 27 August 2026 as the Annual General Meeting.
Record Date3 Jul 2026
The Board Fixed 20 August 2026 As The Record Date For Ascertaining The Members Of The Company For Payment Of Dividend.
20 August 2026 is fixed as Record Date for payment of dividend.
Outcome without intimation3 Jul 2026
Board Meeting Outcome for Board Meeting Outcome For Consideration And Approval Of Annual General Meeting Related Matters
The Board in its meeting approved the AGM related matters and fixed 27 August 2026 as the AGM of the Company
Closure of Trading Window26 Jun 2026
Closure of Trading Window
Intimation of Closure of Trading Window for the quarter ended June 30, 2026
General26 Jun 2026
Updates
Machine Readable Form/Legible copy of Financial Results
General23 Jun 2026
DISCLOSURE REGARDING SECOND 100 DAY CAMPAIGN - "SAKSHAM NIVESHAK"
Campaign for KYC and other related updations and shareholders engagement to prevent transfer of unclaimed dividend to IEPF
General16 Jun 2026
Announcement Under Regulation 30 (LODR)- Updates
Update on acquisition of QliniQ B.V.
Credit Rating9 Jun 2026
Announcement under Regulation 30 (LODR)-Credit Rating
India Ratings and Research has revised the outlook for the Company''s bank loan facilities to Positive from Stable
Analyst / Investor Meet8 Jun 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of schedule for Virtual Investors Conference
Newspaper Publication3 Jun 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication regarding Second 100 day Campaign- "Saksham Niveshak"
General2 Jun 2026
DISCLOSURE REGARDING SECOND 100 DAY CAMPAIGN - "SAKSHAM NIVESHAK"
Campaign for KYC and other related updations and shareholders engagement to prevent transfer of unclaimed dividend to IEPF
Press Release / Media Release1 Jun 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release titled Marksans Pharma Ltd. to acquire 100 percent of Netherland based QliniQ B.V., strengthening presence in European Markets
Analyst / Investor Meet27 May 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio Recording of investor(s) / analyst(s) meet Conference Call on Q4 FY26 Financial Results
Newspaper Publication27 May 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication of Audited Financial Results for the financial year ended 31 March, 2026
Reg.24(A)-Annual Secretarial Compliance27 May 2026
Compliances-Reg.24(A)-Annual Secretarial Compliance
ASCR under Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the year 31, March 2026
Dividend26 May 2026
Corporate Action-Board approves Dividend
The Board has recommended Dividend of Rs. 0.90 per share subject to approval of Shareholders at ensuing Annual General Meeting
Press Release / Media Release26 May 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Marksans Pharma Limited Press Release on Q4 FY26 Results

Frequently Asked Questions

Where can I download the annual report of Marksans Pharma Ltd.?

Annual reports of Marksans Pharma Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Marksans Pharma Ltd.?

Quarterly earnings results and presentations of Marksans Pharma Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Marksans Pharma Ltd. publish earnings call transcripts?

Earnings call transcripts of Marksans Pharma Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Marksans Pharma Ltd.?

Investor presentations and annual day presentations of Marksans Pharma Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Marksans Pharma Ltd.?

Corporate announcements and regulatory filings of Marksans Pharma Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Marksans Pharma Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Marksans Pharma Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Marksans Pharma Ltd.?

The ISIN (International Securities Identification Number) of Marksans Pharma Ltd. is INE750C01026. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Marksans Pharma Ltd. listed?

Marksans Pharma Ltd. is listed on NSE and BSE. The NSE symbol is MARKSANS and the BSE code is -.

Where can I find the shareholding pattern of Marksans Pharma Ltd.?

The quarterly shareholding pattern of Marksans Pharma Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Marksans Pharma Ltd. on Sharpely?

Share price data for Marksans Pharma Ltd. is updated as of 8 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.